Proceeds from the issuance of debt Proceeds from lines of credit Proceeds from Long-Term Lines of Credit Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Statistical Measurement [Domain] Statistical Measurement [Domain] Prepaid expenses Increase (Decrease) in Prepaid Expense Class of warrant or right, conversion terms, threshold trading days Class Of Warrant Or Right, Conversion Terms, Threshold Trading Days Class Of Warrant Or Right, Conversion Terms, Threshold Trading Days Loan Facility, June 30, 2025 Loan Facility, June 30, 2025 [Member] Loan Facility, June 30, 2025 Increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect SOFR floor Debt Instrument, Minimum Variable Rate, SOFR Floor Debt Instrument, Minimum Variable Rate, SOFR Floor Other current liabilities Other Liabilities, Current Trading Symbol Trading Symbol All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Exit fee percentage Line Of Credit Facility, Exit Fee Percentage Line Of Credit Facility, Exit Fee Percentage Non-NEOs Non-NEOs [Member] Share-based payment arrangement, contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Warrants issued, delayed draw commitment amount, percentage Class Of Warrant Or Right, Warrants Issued, Delayed Draw Commitment Amount, Percentage Class Of Warrant Or Right, Warrants Issued, Delayed Draw Commitment Amount, Percentage Nature of Business [Line Items] Nature of Business [Line Items] Nature of Business [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Restricted stock units issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Options Equity Instruments, Issued Share-based Compensation Arrangement by Share-based Payment Award, Non-Options Equity Instruments, Issued Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Income taxes Income Taxes Paid, Net Beginning Balance Ending Balance Accounts Receivable, Allowance for Credit Loss, Current Revenue base redemption liability Revenue Base Redemption Liability Revenue Base Redemption Liability Common stock exchange for warrants (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization Pay vs Performance Disclosure [Line Items] Preferred stock, conversion price (in dollars per share) Preferred Stock, Convertible, Conversion Price Accrued liabilities - clinical trials Accrued Clinical Trial Liability, Current Accrued Clinical Trial Liability, Current Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Loan Facility, Initial Commitment Amount Loan Facility, Initial Commitment Amount [Member] Loan Facility, Initial Commitment Amount Accounts receivable Increase (Decrease) in Accounts Receivable Net Loss per Share Earnings Per Share, Policy [Policy Text Block] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Inventory Inventory, Policy [Policy Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] 24 to 36 Months Prepayment Premium Rate, Period Three [Member] Prepayment Premium Rate, Period Three Purchase agreement, maximum shares allowed, percentage of average daily volume Common Stock, Share Price, Percentage Of Average Daily Volume Common Stock, Share Price, Percentage Of Average Daily Volume Financial Instruments Fair Value Disclosures [Text Block] Proceeds from the exercise of stock options for common stock Proceeds from Stock Options Exercised SPAC Warrants SPAC Warrants [Member] SPAC Warrants Award Timing Disclosures [Line Items] Change in fair value of warrants and SEPA liabilities Loss on change in fair value Derivative, Gain (Loss) on Derivative, Net Other Performance Measure, Amount Other Performance Measure, Amount Share reserve increase, percentage of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Percentage Of Stock, Fully Diluted Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Percentage Of Stock, Fully Diluted Leases Lessee, Operating Leases [Text Block] Common stock, shares outstanding (in shares) Balances, beginning of period (in shares) Balances, end of period (in shares) Common Stock, Shares, Outstanding Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Available for Issue (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Segment Reporting Segment Reporting, Policy [Policy Text Block] Warrants, term Earnout shares vesting requirement, vesting period Warrants and Rights Outstanding, Term Original issue price (in dollars per share) Preferred Stock, Issued Price Per Share Preferred Stock, Issued Price Per Share Plan Name [Domain] Plan Name [Domain] Paid-in-kind interest Debt Instrument, Paid-In-Kind Interest Percentage Debt Instrument, Paid-In-Kind Interest Percentage Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share Beginning balance Ending balance Fair Value, Measurement Reconciliation, Liability Value Fair Value, Measurement Reconciliation, Liability Value Liquidation preference (in dollars per share) Preferred Stock, Liquidation Preference Per Share Other assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Leases [Abstract] Warrants Liabilities Warrant Liability, Policy [Policy Text Block] Warrant Liability, Policy Schedule of Long-Term Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Maximum shares of common stock allowed under Purchase Agreement (in shares) Standby Equity Purchase Agreement, Maximum Amount Of Shares Authorized Standby Equity Purchase Agreement, Maximum Amount Of Shares Authorized Net cash used in operating activities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Secured Debt Secured Debt [Member] Plan Name [Axis] Plan Name [Axis] Prepaid expenses Prepaid Expense, Current Equity Components [Axis] Equity Components [Axis] Class of warrant or right, redemption price (in dollars per share) Class of Warrant or Right, Redemption Price Class of Warrant or Right, Redemption Price Award Timing Method Award Timing Method [Text Block] Research and Development Research and Development Expense, Policy [Policy Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] March 31, 2026 Revenue Base Redemption Feature, Period Five [Member] Revenue Base Redemption Feature, Period Five Accounts Receivable and Customer Concentrations Accounts Receivable [Policy Text Block] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Use of Estimates Use of Estimates, Policy [Policy Text Block] Adjustment to Compensation, Amount Adjustment to Compensation Amount Payables and Accruals [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Supplemental disclosures of non-cash items: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Company Selected Measure Amount Company Selected Measure Amount Series A Convertible Preferred Stock, floor conversion price (in dollars per share) Preferred Stock, Conversion Price, Floor Preferred Stock, Conversion Price, Floor Debt issuance costs Payments of Debt Issuance Costs Tabular List, Table Tabular List [Table Text Block] Tranche Two Derivative Instrument, Period Two [Member] Derivative Instrument, Period Two Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of warrants exchanged (in shares) Class Of Warrant Or Right, Warrants Exchanged Class Of Warrant Or Right, Warrants Exchanged Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Warrants to purchase common stock (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Accounts Receivable, Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss [Table Text Block] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Issuances (Settlements) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) Estimated dividend yield Dividend yield Measurement Input, Expected Dividend Rate [Member] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Impairment and Disposal of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Accrued incentives Accrued Bonuses, Current Asset Acquisition [Axis] Asset Acquisition [Axis] Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Cash, cash equivalents and restricted cash, Total cash, cash equivalents and restricted cash shown in the Condensed Consolidated Statements of Cash Flows Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Private Placement And Working Capital Warrants Private Placement And Working Capital Warrants [Member] Private Placement And Working Capital Warrants Number of leases Lessee, Number Of Operating Leases Lessee, Number Of Operating Leases Warrants and rights outstanding, net of issuance costs Warrants and Rights Outstanding, Net Of Issuance Costs Warrants and Rights Outstanding, Net Of Issuance Costs Revenue base redemption liability Product Revenue Base Redemption [Member] Product Revenue Base Redemption Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Deposits Increase (Decrease) in Deposits Outstanding Current assets: Assets, Current [Abstract] Exercises (in shares) Class Of Warrant Or Right, Warrants Exercised Class of Warrant or Right, Warrants Exercised Threshold number of business days before sending notice of redemption to warrant holders Class Of Warrant Or Right, Conversion Days Notice Class Of Warrant Or Right, Conversion Days Notice Private Placement Warrants Private Warrants [Member] Private Warrants Inventory Inventory Disclosure [Text Block] Nature of Business [Table] Nature of Business [Table] Nature of Business [Table] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Default rate Debt Instrument, Debt Default, Rate Debt Instrument, Debt Default, Rate Entity Information [Line Items] Entity Information [Line Items] Options to purchase common stock Share-Based Payment Arrangement, Option [Member] Fair Value Disclosures [Abstract] Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Accrued taxes Accrued Income Taxes, Current Preferred stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Preferred Stock, Shares Outstanding Security Exchange Name Security Exchange Name Warrants Warrant [Member] PIK interest PIK interest Paid-in-Kind Interest Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Undeclared cumulative dividends Preferred Stock Dividends, Undeclared Cumulative Dividends Preferred Stock Dividends, Undeclared Cumulative Dividends Award Type [Axis] Award Type [Axis] Number of lease renewal options exercised Lessee, Operating Lease, Number Of Renewal Options Exercised Lessee, Operating Lease, Number Of Renewal Options Exercised Common stock, shares authorized, standby equity purchase agreement (in shares) Common Stock, Shares Authorized, Standby Equity Purchase Agreement Common Stock, Shares Authorized, Standby Equity Purchase Agreement Contingent earnout liability Contingent Earnout Liability [Member] Contingent Earnout Liability Lease Contractual Term [Domain] Lease Contractual Term [Domain] Class of warrant or right, conversion terms, threshold consecutive trading days Class of Warrant or Right, Conversion Terms, Threshold Consecutive Trading Days Class of Warrant or Right, Conversion Terms, Threshold Consecutive Trading Days Total liabilities Liabilities Stock options issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Issued Share-based Compensation Arrangement by Share-based Payment Award, Options, Issued Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Increase in common stock reserve for future issuance (in shares) Common Stock, Period Increase (Decrease) in Capital Shares Reserved for Future Issuance Common Stock, Period Increase (Decrease) In Capital Shares Reserved For Future Issuance Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Research and development Research and Development Expense Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Expiration Date Trading Arrangement Expiration Date Purchase agreement, sales price, percentage of market price during three consecutive trading days Share Price As Percentage Of Market Price With Advance Notice, Option Two Share Price As Percentage Of Market Price With Advance Notice, Option Two Proceeds from the issuance of preferred stock Proceeds from Issuance of Convertible Preferred Stock Class of warrant or right, number of securities called by each warrant or right (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Total Shareholder Return Amount Total Shareholder Return Amount Common stock, shares issued (in shares) Common Stock, Shares, Issued Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Line of credit maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Product revenue base, minimum amount required Line Of Credit Facility, Product Revenue Base, Minimum Threshold Amount Line Of Credit Facility, Product Revenue Base, Minimum Threshold Amount Exercise of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Debt Instrument [Line Items] Debt Instrument [Line Items] Revenue Base Redemption Liability Revenue Base Redemption Liability, Policy [Policy Text Block] Revenue Base Redemption Liability, Policy Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Class of Warrant or Right [Table] Class of Warrant or Right [Table] Retirements/Conversions (in shares) Temporary Equity, Stock Retired Or Converted During Period, Shares Temporary Equity, Stock Retired Or Converted During Period, Shares Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Weighted average common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Number of warrants after split Class Of Warrant Or Right, Warrant Split, Number Of New Warrants Class Of Warrant Or Right, Warrant Split, Number Of New Warrants Total stockholders’ deficit Balance, beginning of period Balance, end of period Equity, Attributable to Parent Shares issuable under the SEPA Standby Equity Purchase Agreement (SEPA) [Member] Standby Equity Purchase Agreement (SEPA) Expected draws Derivative liability, measurement input Derivative Liability, Measurement Input Royalties as a percentage of net sales, under sales threshold Asset Acquisition, Royalty Percentage, Under Threshold Amount Asset Acquisition, Royalty Percentage, Under Threshold Amount Lease renewal term Lessee, Operating Lease, Renewal Term Issuances (in shares) Temporary Equity, Shares Issued During Period Temporary Equity, Shares Issued During Period Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Interest expense Interest Expense, Nonoperating Change in fair value of SEPA, warrant, and revenue base redemption liabilities Gain (Loss) On Change In Fair Value Of Warrants And Other Liabilities Gain (Loss) On Change In Fair Value Of Warrants And Other Liabilities Accrued payroll Accrued Salaries, Current Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Write-off of uncollectible receivables Accounts Receivable, Allowance for Credit Loss, Writeoff Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Share-based compensation arrangement by share-based payment award, automatic increase, percentage of total shares Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Total Shares Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Total Shares Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Options and RSU's outstanding (in shares) Authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Sale of Stock [Domain] Sale of Stock [Domain] Long-term debt, beginning balance Long-term debt, ending balance Long-Term Debt Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus Document Fiscal Period Focus All Executive Categories All Executive Categories [Member] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Assets Assets [Abstract] Shares returned Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Shares Returned From Options Exercised, Correction Of Clerical Error Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Shares Returned From Options Exercised, Correction Of Error Restricted stock units outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Document Type Document Type Commitment fee percentage Line of Credit Facility, Commitment Fee Percentage Temporary Equity Disclosure [Abstract] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Exchange ratio (in shares) Recapitalization Exchange Ratio Recapitalization Exchange Ratio Contingent earnout liability Business Combination, Contingent Consideration, Liability, Noncurrent June 30, 2025 Revenue Base Redemption Feature, Period Two [Member] Revenue Base Redemption Feature, Period Two Lessee, number of finance leases Lessee, Number Of Finance Leases Lessee, Number Of Finance Leases Maximum Maximum [Member] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Change in Unrealized (Gains) Losses Fair Value, Liability, Still Held, Unrealized Gain (Loss) Fair Value, Liability, Still Held, Unrealized Gain (Loss) Accounting Policies [Abstract] June 30, 2026 and each Fiscal Quarter ending thereafter Revenue Base Redemption Feature, Period Six And Thereafter [Member] Revenue Base Redemption Feature, Period Six And Thereafter Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Undeclared dividends on Series A preferred stock Preferred Stock Dividends, Income Statement Impact Reverse Recapitalization [Line Items] Reverse Recapitalization [Line Items] Reverse Recapitalization Earnout period, threshold trading days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days Current Fiscal Year End Date Current Fiscal Year End Date Share reserve increase, number of years Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Number of Years Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Number of Years Statistical Measurement [Axis] Statistical Measurement [Axis] PEO Name PEO Name Warrants outstanding (in shares) Warrants outstanding, beginning balance (in shares) Warrants outstanding, ending balance (in shares) Class of Warrant or Right, Outstanding Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares purchased in ESPP offering (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Award Type [Domain] Award Type [Domain] Royalties as a percentage of sales, over threshold amount Asset Acquisition, Royalty Percentage, Over Threshold Amount Asset Acquisition, Royalty Percentage, Over Threshold Amount Automatic conversion, anniversary Preferred Stock, Automatic Conversion, Period Preferred Stock, Automatic Conversion, Period Name Outstanding Recovery, Individual Name Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Revision of Prior Period [Axis] Revision of Prior Period [Axis] Non-PEO NEO Non-PEO NEO [Member] Additional paid-in capital Additional Paid-in Capital [Member] Maximum aggregate milestone payments per development milestone Asset Acquisition, Maximum Milestone Amount Asset Acquisition, Maximum Milestone Amount Award Timing Predetermined Award Timing Predetermined [Flag] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Westminster Facility Westminster Facility [Member] Westminster Facility Warrants and Rights Note Disclosure [Abstract] Restricted cash (included in Other assets) Restricted Cash, Noncurrent Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Stock net yet issued, price per share (in dollars per share) Sale Of Stock, Not Yet Issued, Price Per Share Sale Of Stock, Not Yet Issued, Price Per Share Net loss per common share, diluted (in dollars per share) Earnings Per Share, Diluted Class of Stock [Axis] Class of Stock [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Reduction in the carrying amount of right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Name Measure Name Prepayment Premium Rate, Period [Domain] Prepayment Premium Rate, Period [Domain] Prepayment Premium Rate, Period [Domain] Entity Interactive Data Current Entity Interactive Data Current Accrued vacation Accrued Vacation, Current Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Schedule of Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Warrant holder support for Warrant Agreement Class Of Warrant Or Right, Percentage of Warrants, Tender Agreement Class Of Warrant Or Right, Percentage of Warrants, Tender Agreement Revenue base redemption feature, amount Revenue base redemption liability Revenue Base Redemption Feature, Amount Revenue Base Redemption Feature, Amount Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Statement of Financial Position [Abstract] Contingent earnout liability, measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Sales and marketing Selling and Marketing Expense Issuances (Settlements) Fair Value, Measurement Reconciliation, Liability, Purchases, (Sales), Issuances, (Settlements) Fair Value, Measurement Reconciliation, Liability, Purchases, (Sales), Issuances, (Settlements) Proceeds from the disposal of property and equipment Proceeds from Sale of Property, Plant, and Equipment Dynavax Technologies Dynavax Technologies [Member] Dynavax Technologies Income tax expense Income Tax Expense (Benefit) SEPA derivative liability Standby Equity Purchase Agreement (SEPA) Derivative Liability [Member] Standby Equity Purchase Agreement (SEPA) Derivative Liability Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Warrant liability Warrant Liability Warrant Liability Unrecognized compensation expense, recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Revenue Revenue from Contract with Customer, Excluding Assessed Tax Preferred stock, dividend rate, percentage Preferred Stock, Dividend Rate, Percentage Effective federal tax rate Effective Income Tax Rate Reconciliation, Percent Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Loss from operations Loss from operations Operating Income (Loss) Proceeds from private placement Proceeds from Issuance of Private Placement Additional number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Number of reportable segments Number of Reportable Segments Total liabilities and stockholders’ deficit Liabilities and Equity Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Additional paid-in capital Additional Paid in Capital Number of debt increments available to be drawn Number Of Debt Increments Available To Be Drawn Number Of Debt Increments Available To Be Drawn Contingent Earnout Liability Standby Equity Purchase Agreement Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Commitments and Contingencies Disclosure [Abstract] Interest income Investment Income, Interest Right-of-use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Underlying Security Market Price Change Underlying Security Market Price Change, Percent Fair Value, Liabilities Measurement Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measurement Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measurement Reconciliation, Calculation Measurement Input Type [Axis] Measurement Input Type [Axis] Individual: Individual [Axis] Inventory, net Inventory, net Inventory, Net Revenue Base Redemption Feature, Period [Axis] Revenue Base Redemption Feature, Period [Axis] Revenue Base Redemption Feature, Period Class of Warrant or Right [Roll Forward] Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity Address, State or Province Entity Address, State or Province Statement [Line Items] Statement [Line Items] Measurement Input Type [Domain] Measurement Input Type [Domain] Derivative Instruments and Hedging Activities Disclosure [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Trade payables Accounts Payable, Trade, Current Operating expenses: Operating Expenses [Abstract] Derivative liability, measurement input Warrant Liability, Measurement Input Warrant Liability, Measurement Input Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Purchase agreement period Standby Equity Purchase Agreement, Term Standby Equity Purchase Agreement, Term Alliance program, term Alliance Program, Term Alliance Program, Term Liabilities and Stockholders’ Deficit Liabilities and Equity [Abstract] Cash paid for interest expense Interest Paid, Capitalized, Investing Activities SEPA derivative liability Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Expected draws Measurement Input, Expected Draws [Member] Measurement Input, Expected Draws Schedule of Error Corrections and Prior Period Adjustments Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] Standby Equity Purchase Agreement Derivatives, Policy [Policy Text Block] Minimum Minimum [Member] Restatement Determination Date Restatement Determination Date Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Number of equity incentive plans Number of Equity Incentive Plans Number of Equity Incentive Plans Right-of-use assets Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Stock options outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Amount charged (recovered) to costs and expenses Amount charged (recovered) to costs and expenses Accounts Receivable, Credit Loss Expense (Reversal) Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Share-Based Compensation Plan Balances Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Conversion price, second automatic reset Preferred Stock, Conversion Price, Automatic Reset Duration, Second Reset Preferred Stock, Conversion Price, Automatic Reset Duration, Second Reset Earnout shares vesting percentage Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Exercise Price Award Exercise Price Lease Contractual Term [Axis] Lease Contractual Term [Axis] Preferred stock available for future issuance (in shares) Preferred Stock, Capital Shares Reserved for Future Issuance Convertible Preferred Stock Preferred Stock [Text Block] Asset Acquisition [Table] Asset Acquisition [Table] Revenue recognition, rebates recognized Revenue Recognition, Rebates Recognized Revenue Recognition, Rebates Recognized Net Loss Per Share Earnings Per Share [Text Block] Arrangement Duration Trading Arrangement Duration Revision of Prior Period, Error Correction, Adjustment Revision of Prior Period, Error Correction, Adjustment [Member] Subsequent Event Subsequent Event [Member] Leases Lessee, Finance Leases [Text Block] Exercise of options Stock Issued During Period, Value, Stock Options Exercised Working capital warrants Working Capital Warrants Working Capital Warrants [Member] Working Capital Warrants RSU weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Income Taxes Income Tax, Policy [Policy Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Initial OrbiMed Warrant, Substitute Warrant Certificate Number Two Initial OrbiMed Warrant, Substitute Warrant Certificate Number Two [Member] Initial OrbiMed Warrant, Substitute Warrant Certificate Number Two Share-based compensation arrangement by share-based payment award, automatic increase, percentage of initial share reserve Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Initial Share Reserve Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Initial Share Reserve Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Revenue Base Redemption Feature, Period [Domain] Revenue Base Redemption Feature, Period [Domain] Revenue Base Redemption Feature, Period [Domain] OrbiMed Warrants liability OrbiMed Warrants OrbiMed Warrants [Member] OrbiMed Warrants All Individuals All Individuals [Member] Outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Outstanding PEO PEO [Member] Temporary Equity [Line Items] Temporary Equity [Line Items] Initial OrbiMed Warrant Initial OrbiMed Warrant [Member] Initial OrbiMed Warrant Income Tax Disclosure [Abstract] Name Trading Arrangement, Individual Name Royalties, sales threshold amount Asset Acquisition, Royalties, Sales Threshold Amount Asset Acquisition, Royalties, Sales Threshold Amount Other expense, net Other Nonoperating Income (Expense) Number of lease renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Non-cash interest expense Noncash Interest Expense Noncash Interest Expense Statement of Stockholders' Equity [Abstract] Purchase agreement, number of trading days used for measurement of market price Common Stock, Share Price, Market Price, Number Of Consecutive Trading Days Common Stock, Share Price, Market Price, Number Of Consecutive Trading Days Unrecognized compensation expense, RSUs Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Preferred stock conversion (in shares) Preferred Stock Conversion, Shares Preferred Stock Conversion, Shares Undrawn fee, percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage December 31, 2025 Revenue Base Redemption Feature, Period Four [Member] Revenue Base Redemption Feature, Period Four Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Other income (expense): Other Nonoperating Income (Expense) [Abstract] Common stock warrants Common Stock Warrant [Member] Common Stock Warrant Common stock reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Expected share price volatility Expected volatility Measurement Input, Price Volatility [Member] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Long-term lease liabilities Lease Liability, Noncurrent Lease Liability, Noncurrent Local Phone Number Local Phone Number Liability Class [Axis] Liability Class [Axis] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Asset Acquisition [Line Items] Asset Acquisition [Line Items] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Stock converted, reverse recapitalization (in shares) Stock Converted, Reverse Recapitalization Stock Converted, Reverse Recapitalization Standby equity purchase agreement, maximum allowable percentage of outstanding common stock Standby Equity Purchase Agreement, Maximum Allowable Percentage Of Outstanding Common Stock Standby Equity Purchase Agreement, Maximum Allowable Percentage Of Outstanding Common Stock PEO Total Compensation Amount PEO Total Compensation Amount Stock options exercise price, percentage of fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Subsequent OrbiMed Warrants Subsequent OrbiMed Warrants [Member] Subsequent OrbiMed Warrants Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Class of warrant or right, threshold number of days for warrants to be transferable Class of Warrant or Right, Threshold Number of Days for Warrants to be Transferable Class of Warrant or Right, Threshold Number of Days for Warrants to be Transferable Entity Ex Transition Period Entity Ex Transition Period Cash, Cash Equivalents, and Restricted Cash Cash and Cash Equivalents, Policy [Policy Text Block] Bannockburn Facility Bannockburn Facility [Member] Bannockburn Facility Commitments And Contingencies Commitments and Contingencies Disclosure [Text Block] Change in fair value of OrbiMed Warrants and revenue base redemption liabilities Gain (Loss) On Change In Fair Value Of Revenue Base Redemption And Warrant Liability Gain (Loss) On Change In Fair Value Of Revenue Base Redemption And Warrant Liability Debt Disclosure [Abstract] Common stock, $0.0001 par value Common stock Common Stock [Member] Measure: Measure [Axis] Share-based compensation arrangement by share-based payment award, automatic increase period Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase Period Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase Period Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Summary of Changes in Fair Value of Outstanding Warrant and Tranche Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Proceeds from sale of common stock (in shares) Issuances (in shares) Stock Issued During Period, Shares, New Issues Tranche Four Derivative Instrument, Period Four [Member] Derivative Instrument, Period Four Entity Emerging Growth Company Entity Emerging Growth Company Public Warrants, Private Placement Warrants And Working Capital Warrants Public Warrants, Private Placement Warrants And Working Capital Warrants [Member] Public Warrants, Private Placement Warrants And Working Capital Warrants Issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Entity Central Index Key Entity Central Index Key Business Combination Reverse Recapitalization Disclosure [Text Block] Reverse Recapitalization Disclosure Summary of Components of Inventory Schedule of Inventory, Current [Table Text Block] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Trade payables and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Convertible preferred stock, beginning balance (in shares) Convertible preferred stock, ending balance (in shares) Temporary Equity, Shares Outstanding Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Accretion of exit fee liability Accretion Expense Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Change in fair value of contingent earnout liability Change in fair value of contingent earnout liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Title Trading Arrangement, Individual Title Statement [Table] Statement [Table] Interest expense Interest Expense, Debt Purchase agreement, sales price, percentage of market price Share Price As Percentage Of Market Price Commencing On Advance Notice Date Share Price As Percentage Of Market Price Commencing On Advance Notice Date Counterparty Name [Axis] Counterparty Name [Axis] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] City Area Code City Area Code Current liabilities: Liabilities, Current [Abstract] Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Level 1 Fair Value, Inputs, Level 1 [Member] Class Of Warrant Or Right, Number Of Operating Entities Holding Warrants Class Of Warrant Or Right, Number Of Operating Entities Holding Warrants Class Of Warrant Or Right, Number Of Operating Entities Holding Warrants Total current assets Assets, Current Statement of Cash Flows [Abstract] Revision of Prior Period [Domain] Revision of Prior Period [Domain] Preferred stock Preferred Stock [Member] Fair value of warrants issued related to OrbiMed debt Warrants Issued In Connection With Debt, Value Warrants Issued In Connection With Debt, Value March 31, 2025 Revenue Base Redemption Feature, Period One [Member] Revenue Base Redemption Feature, Period One Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] 12 to 24 Months Prepayment Premium Rate, Period Two [Member] Prepayment Premium Rate, Period Two Long-term debt, net of unamortized discount and debt issuance costs Long-Term Debt, Excluding Current Maturities Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Options, weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Expected term (years) Measurement Input, Expected Term [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Income Taxes Income Tax Disclosure [Text Block] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Stockholders’ deficit: Equity [Abstract] Paid in kind interest, term Debt Instrument, Paid-In-Kind Interest, Term Debt Instrument, Paid-In-Kind Interest, Term Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Class of Stock [Domain] Class of Stock [Domain] Inventory, net Increase (Decrease) in Inventories Supplemental disclosures of cash flow information: Supplemental Cash Flow Elements [Abstract] General and administrative General and Administrative Expense Issuances (in shares) Class Of Warrant Or Right, Shares Issued During Period Class Of Warrant Or Right, Shares Issued During Period Organization, Consolidation and Presentation of Financial Statements [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Administrative fee Debt Instrument, Fee Amount Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Underlying Securities Award Underlying Securities Amount Derecognition of finance lease right-of-use asset Derecognition Of Finance Lease Right-Of-Use Asset Derecognition Of Finance Lease Right-Of-Use Asset Within 12 Months Prepayment Premium Rate, Period One [Member] Prepayment Premium Rate, Period One Amendment Flag Amendment Flag Debt Instrument, Activity [Roll Forward] Debt Instrument, Activity [Roll Forward] Debt Instrument, Activity Entity Registrant Name Entity Registrant Name Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Debt instrument, prepayment premium rate Debt Instrument, Prepayment Premium Rate Debt Instrument, Prepayment Premium Rate Derivative instrument, contingent consideration, liability, earnout period Derivative Instrument, Contingent Consideration, Liability, Earnout Period Derivative Instrument, Contingent Consideration, Liability, Earnout Period Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Gross profit Gross Profit Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] After 48 Months Prepayment Premium Rate, Period Five [Member] Prepayment Premium Rate, Period Five Fair Value as of Grant Date Award Grant Date Fair Value Warrant redemption condition, share price (in dollars per share) Class Of Warrant Or Right, Conversion Stock Price Threshold Class Of Warrant Or Right, Conversion Stock Price Threshold Level 2 Fair Value, Inputs, Level 2 [Member] Sale of stock (in shares) Sale of Stock, Number of Shares Issued in Transaction Debt Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Shares unvested (in shares) Contingent Consideration, Liability, Shares Number of Shares Unvested Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Proceeds from sale of common stock Issuance of stock Stock Issued During Period, Value, New Issues Warrant and SEPA liabilities Derivative Liability, Noncurrent Entity Address, Postal Zip Code Entity Address, Postal Zip Code Advertising expense Advertising Expense Purchase agreement, ownership limitation Class Of Warrant Or Right, Ownership Limitation Class Of Warrant Or Right, Ownership Limitation Restatement Determination Date: Restatement Determination Date [Axis] Title of 12(b) Security Title of 12(b) Security Common stock, $0.0001 par value per share. Authorized 400,000,000 shares at March 31, 2025 and December 31, 2024, respectively; issued and outstanding, 32,272,462 and 31,279,264 shares at March 31, 2025, and December 31, 2024, respectively. Common Stock, Value, Issued 2009 Plan 2009 Plan [Member] 2009 Plan Derivative Instrument, Period [Axis] Derivative Instrument, Period [Axis] Derivative Instrument, Period Share-Based Payment Arrangement [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value September 30, 2025 Revenue Base Redemption Feature, Period Three [Member] Revenue Base Redemption Feature, Period Three Restricted And Performance Stock Units Restricted Stock Units And Performance Shares [Member] Restricted Stock Units And Performance Shares Change in Unrealized (Gains) Losses Change in unrealized gain Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Public Warrants Public Warrants [Member] Public Warrants Raw materials Inventory, Raw Materials, Gross Sale of stock, authorized amount Sale Of Stock, Authorized Amount, Value Sale Of Stock, Authorized Amount, Value Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Preferred Stock, Convertible Series A, $0.0001 par value per share, $10.00 liquidation value per share. Authorized 10,000,000 shares at March 31, 2025 and December 31, 2024, respectively; issued and outstanding, 3,620,002 and 3,985,002 shares at March 31, 2025, and December 31, 2024, respectively. Preferred Stock, Value, Issued Finished goods Inventory, Finished Goods, Gross Property, plant and equipment, useful life Property, Plant and Equipment, Useful Life Employee Stock Employee Stock [Member] Retirements/Conversions (in shares) Class of Warrant Or Right, Conversion And Retirements Of Convertible Securities Class of Warrant Or Right, Conversion And Retirements Of Convertible Securities Depreciation Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Net loss per common share, basic (in dollars per share) Earnings Per Share, Basic Proceeds from the issuance of common stock Proceeds from Issuance of Common Stock Subsequent OrbiMed Warrants, Entity One Subsequent OrbiMed Warrants, Entity One [Member] Subsequent OrbiMed Warrants, Entity One Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Share-based compensation arrangement by share-based payment award, expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Property and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Payments on finance lease liabilities Finance Lease, Principal Payments Loan Facility Loan Facility [Member] Loan Facility Fixed asset purchases included in trade payables and accrued expenses Capital Expenditures Incurred but Not yet Paid Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Net loss attributable to common stockholders Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Total current liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Tranche One Derivative Instrument, Period One [Member] Derivative Instrument, Period One Unrecognized compensation expense, options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Previously Reported Previously Reported [Member] Total assets Assets Concentrations of Credit Risk and Other Risks and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Cost of goods sold Cost of Goods and Services Sold Advertising Advertising Cost [Policy Text Block] Cash and Cash Equivalents [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Earnout shares vesting requirement, weighted average price per share (in dollars per share) Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Number of trading days, VWAP Preferred Stock, Number of Trading Days, Volume Weighted Average Price Preferred Stock, Number of Trading Days, Volume Weighted Average Price Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Commitments and contingencies Commitments and Contingencies Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] 2023 Plan 2023 Plan [Member] 2023 Plan Contingent Earnout Liability Business Combinations Policy [Policy Text Block] Dynavax Purchase Asset Acquisition [Text Block] 36 to 48 Months Prepayment Premium Rate, Period Four [Member] Prepayment Premium Rate, Period Four Commercial Milestone Commercial Milestone [Member] Commercial Milestone Termination Date Trading Arrangement Termination Date Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Conversion price, first automatic reset Preferred Stock, Conversion Price, Automatic Reset Duration, First Reset Preferred Stock, Conversion Price, Automatic Reset Duration, First Reset Nature of Business Nature of Operations [Text Block] Exercise price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Subsequent OrbiMed Warrants, Entity Two Subsequent OrbiMed Warrants, Entity Two [Member] Subsequent OrbiMed Warrants, Entity Two Share-Based Compensation Share-Based Payment Arrangement [Text Block] Purchase agreement, number of days used for measurement of average daily trading volume Common Stock, Share Price, Average Daily Volume, Number Of Trading Days Common Stock, Share Price, Average Daily Volume, Number Of Trading Days Upfront payment Asset Acquisition, Consideration Transferred Entity Address, City or Town Entity Address, City or Town Leases Lessee, Leases [Policy Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Schedule of Convertible Preferred Stock Temporary Equity [Table Text Block] Net loss available to common stockholders Net loss Net loss available to common stockholders Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Reverse Recapitalization [Abstract] Reverse Recapitalization Non-cash interest expense Amortization of Debt Discount (Premium) Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Sale of stock, shares to be issued in transaction (in shares) Sale Of Stock, Number Of Shares To Be Issued In Transaction Sale Of Stock, Number Of Shares To Be Issued In Transaction Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Payments for milestone Payments for Asset Acquisition, Milestone Amount Payments for Asset Acquisition, Milestone Amount Entity File Number Entity File Number Document Fiscal Year Focus Document Fiscal Year Focus Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Accrued liabilities - general Other Accrued Liabilities, Current Name Forgone Recovery, Individual Name Commercial Milestone Type [Domain] Commercial Milestone Type [Domain] Commercial Milestone Type [Domain] Derivative Instrument, Period [Domain] Derivative Instrument, Period [Domain] Derivative Instrument, Period [Domain] Document Period End Date Document Period End Date Series A Convertible Preferred Stock Series A Convertible Preferred Stock [Member] Series A Convertible Preferred Stock Sale of Stock [Axis] Sale of Stock [Axis] Short-term lease liabilities Lease Liability, Current Lease Liability, Current Commercial Milestone Type [Axis] Commercial Milestone Type [Axis] Commercial Milestone Type University Of Texas MD Anderson Cancer Center University Of Texas MD Anderson Cancer Center [Member] University Of Texas MD Anderson Cancer Center Reserve for obsolete inventory Inventory Valuation Reserves Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Rent payments Lessee, Operating Lease, Liability, to be Paid Insider Trading Arrangements [Line Items] Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents Disclosure [Text Block] Inventory Disclosure [Abstract] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Earnout period, threshold consecutive trading days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days Tranche Three Derivative Instrument, Period Three [Member] Derivative Instrument, Period Three PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Current stock price Stock price Measurement Input, Share Price [Member] Outstanding warrant liabilities Warrants and Rights Outstanding Adjustment to Compensation: Adjustment to Compensation [Axis] Expected probability of draws Measurement Input, Expected Probably of Draws [Member] Measurement Input, Expected Probably of Draws Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Initial OrbiMed Warrant, Substitute Warrant Certificate Number One Initial OrbiMed Warrant, Substitute Warrant Certificate Number One [Member] Initial OrbiMed Warrant, Substitute Warrant Certificate Number One Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Entity Current Reporting Status Entity Current Reporting Status Exercise of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Net Of Shares Returned Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Net Of Shares Returned Accumulated deficit Retained Earnings [Member] Prepayment Premium Rate, Period [Axis] Prepayment Premium Rate, Period [Axis] Prepayment Premium Rate, Period Amortization of debt issuance costs Amortization of Debt Issuance Costs Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Asset Acquisition [Domain] Asset Acquisition [Domain] Weighted average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Exercise price Measurement Input, Exercise Price [Member] Document Information [Table] Document Information [Table] RSUs Restricted Stock Units (RSUs) [Member] Standby Equity Purchase Agreement Standby Equity Purchase Agreement [Member] Standby Equity Purchase Agreement Fixed asset purchase through exchange of finance lease right-of-use asset Fixed Asset Purchase Through Exchange Of Finance Lease Right-Of-Use Asset Fixed Asset Purchase Through Exchange Of Finance Lease Right-Of-Use Asset Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] Name Awards Close in Time to MNPI Disclosures, Individual Name Number of commercial milestones Asset Acquisition, Number of Commercial Milestones Asset Acquisition, Number of Commercial Milestones Entity Filer Category Entity Filer Category Warrants Warrants Liabilities [Text Block] Warrants Liabilities Loan Facility, December 31, 2025 Loan Facility, December 31, 2025 [Member] Loan Facility, December 31, 2025 Company Selected Measure Name Company Selected Measure Name Private Placement Private Placement [Member]